US 6379670
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
expired A61KA61K38/00
Quick answer
US patent 6379670 (Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein) held by Neurocrine Biosciences, Inc. expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K38/00